CLINICAL TRIALS PROFILE FOR NALMEFENE HYDROCHLORIDE
✉ Email this page to a colleague
All Clinical Trials for Nalmefene Hydrochloride
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00000437 ↗ | Tobacco Dependence in Alcoholism Treatment (Nicotine Patch/Naltrexone) | Completed | National Institute on Alcohol Abuse and Alcoholism (NIAAA) | Phase 4 | 1997-09-26 | The purpose of this study is to determine the effectiveness of naltrexone (Revia) or matched placebo combined with nicotine patch (Nicotrol) or placebo patch using a 2x2 design in reducing drinking and smoking in patients with both nicotine and alcohol dependence. |
NCT00000437 ↗ | Tobacco Dependence in Alcoholism Treatment (Nicotine Patch/Naltrexone) | Completed | The Scripps Research Institute | Phase 4 | 1997-09-26 | The purpose of this study is to determine the effectiveness of naltrexone (Revia) or matched placebo combined with nicotine patch (Nicotrol) or placebo patch using a 2x2 design in reducing drinking and smoking in patients with both nicotine and alcohol dependence. |
NCT00000450 ↗ | Naltrexone Maintenance Treatment of Alcoholism | Completed | National Institute on Alcohol Abuse and Alcoholism (NIAAA) | Phase 4 | 1997-04-10 | The purpose of this study is to determine the long-term effectiveness of naltrexone treatment in alcohol-dependent patients who respond to short-term treatment. Those who respond to short-term treatment will be randomized to a 1-year, double-blind, placebo-controlled maintenance phase with a 6-month posttreatment followup. |
NCT00000450 ↗ | Naltrexone Maintenance Treatment of Alcoholism | Completed | The Scripps Research Institute | Phase 4 | 1997-04-10 | The purpose of this study is to determine the long-term effectiveness of naltrexone treatment in alcohol-dependent patients who respond to short-term treatment. Those who respond to short-term treatment will be randomized to a 1-year, double-blind, placebo-controlled maintenance phase with a 6-month posttreatment followup. |
NCT00132119 ↗ | Nalmefene Gambling Study: Study of Nalmefene HCl in the Treatment of Pathological Gambling | Completed | Somaxon Pharmaceuticals | Phase 2/Phase 3 | 2005-08-01 | The purpose of this study is to determine if nalmefene is safe and effective in the treatment of pathological gambling. |
NCT00202696 ↗ | Nalmefene Smoking Cessation Study | Completed | Somaxon Pharmaceuticals | Phase 2 | 2005-09-01 | To determine if nalmefene is safe and effective in smoking cessation. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Nalmefene Hydrochloride
Condition Name
Clinical Trial Locations for Nalmefene Hydrochloride
Trials by Country
Clinical Trial Progress for Nalmefene Hydrochloride
Clinical Trial Phase
Clinical Trial Sponsors for Nalmefene Hydrochloride
Sponsor Name